Trial Profile
An Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Long-Term Oral Lacosamide for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jan 2018
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Generalised epilepsy
- Focus Adverse reactions
- Sponsors UCB
- 03 May 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.
- 20 Mar 2014 New trial record